Insiders sold $21.3 million in the last 90 days with zero purchases, while institutional net value dropped $35.3 billion and exits outnumbered new buys 252 to 141.

Confirmation

A continued insider selling streak with no insider buying in the next filing would confirm the bearish trend.

Invalidation Risk

A sudden cluster of insider purchases or a positive reversal in institutional net value change would invalidate this bearish stance.

The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice and should not be used as the basis for any buy or sell decision.

Insider Trading (Form 4)

90d confidence

unique buyers

—

buy value

data as of 2026-07-16

12-Month Buy/Sell Activity

Apr 25

Jul 25

Oct 25

Jan 26

BuySell

操作	內部人	職稱	交易日	金額
賣出	Curet Myriam	EVP & Chief Medical Officer	2026-03-10	$52K
賣出	Brosius Mark	SVP & Chief Mfg and Supply Cha	2026-03-09	$313K
賣出	Brosius Mark	SVP & Chief Mfg and Supply Cha	2026-03-06	$318K
賣出	Brosius Mark	SVP & Chief Mfg and Supply Cha	2026-03-05	$321K
賣出	Brosius Mark	SVP & Chief Mfg and Supply Cha	2026-03-04	$1.18M
賣出	Brosius Mark	SVP & Chief Mfg and Supply Cha	2026-03-03	$316K
賣出	Widman Fredrik	VP Corporate Controller	2026-03-03	$57K
賣出	Curet Myriam	EVP & Chief Medical Officer	2026-03-03	$2.30M

View all insider trades →

Form 144 Pre-Sale Notices

Filings (90d)

$5.47M

Total Est. Value

14K shares

Planned Shares

Last Filed 2026-06-10

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
LOEB GARY	Officer	2026-06-10	400 shares	$171K
Brosius Mark	Officer	2026-06-08	665 shares	$281K
Johnson Amal M	Director	2026-06-03	12K shares	$5.02M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-16

2026-07-16

Intuitive Surgical filed a Form 8-K on July 16, 2026, announcing its financial results under Item 2.02. The filing includes Exhibit 99.1, but the excerpt does not provide any specific figures. This is a routine earnings disclosure.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding INTUITIVE SURGICAL INC (ISRG)?

Major stakeholders currently include BlackRock, Inc. ($13.9B), Vanguard Capital Management LLC ($10.6B), State Street CORP ($7.3B). Based on the latest 13F filings, there are a total of 2312 tracked investment funds and institutions maintaining positions in ISRG.

What is the overall institutional sentiment toward ISRG recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $35.3B, driven by 1135 managers accumulating shares while 1093 reduced their exposure.

Which institutions have been selling or reducing their ISRG positions?

In the latest period, 841 funds trimmed their holdings, and 252 managers completely exited their positions. The aggregate reported sell value was $82.5B.

Are there any notable investors adding ISRG to their portfolios?

Yes, buying activity remains notable. 141 institutions opened new positions in {ticker}, and 994 existing holders added to their shares. The total reported buy value for the quarter amounted to $65.3B.